======= ACADM ======= == Gene Information == * **Official Symbol**: ACADM * **Official Name**: acyl-CoA dehydrogenase medium chain * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=34|34]] * **UniProt**: [[https://www.uniprot.org/uniprot/P11310|P11310]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ACADM&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACADM|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607008|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the medium-chain specific (C4 to C12 straight chain) acyl-Coenzyme A dehydrogenase. The homotetramer enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Defects in this gene cause medium-chain acyl-CoA dehydrogenase deficiency, a disease characterized by hepatic dysfunction, fasting hypoglycemia, and encephalopathy, which can result in infantile death. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Acyl-CoA dehydrogenase specific for acyl chain lengths of 4 to 16 that catalyzes the initial step of fatty acid beta- oxidation. Utilizes the electron transfer flavoprotein (ETF) as an electron acceptor to transfer electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase). {ECO:0000269|PubMed:25416781}. |Acyl-CoA dh N| |Acyl-CoA dh 1| |Acyl-CoA dh M| |Acyl-CoA dh 2| |medium-chain-acyl-CoA dehydrogenase activity| |carnitine metabolic process, CoA-linked| |carnitine biosynthetic process| |medium-chain fatty acid catabolic process| |acyl-CoA dehydrogenase activity| |amino-acid betaine biosynthetic process| |fatty acid beta-oxidation using acyl-CoA dehydrogenase| |medium-chain fatty acid metabolic process| |carnitine metabolic process| |amino-acid betaine metabolic process| |cellular modified amino acid biosynthetic process| |flavin adenine dinucleotide binding| |fatty acid beta-oxidation| |fatty acid oxidation| |lipid oxidation| |fatty acid catabolic process| |mitochondrial membrane| |monocarboxylic acid catabolic process| |ammonium ion metabolic process| |cellular lipid catabolic process| |cellular modified amino acid metabolic process| |lipid modification| |organic acid catabolic process| |carboxylic acid catabolic process| |axon| |lipid catabolic process| |fatty acid metabolic process| |mitochondrial matrix| |regulation of lipid metabolic process| |nuclear speck| |small molecule catabolic process| |monocarboxylic acid metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |identical protein binding| |lipid metabolic process| |mitochondrion| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp486|Heregulin-B 44ng/ml R08 exp486]]|1.93| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.451| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10899 * **Expression level (log2 read counts)**: 6.17 {{:chemogenomics:nalm6 dist.png?nolink |}}